Clinical implications of uterine malformations and hysteroscopic treatment results.

By G. Grimbizis, M. Camus, B. Tarlatzis, J. Bontis, P. Devroey. Human Reproduction Update, 2001

944 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

The ESHRE/ESGE consensus on the classification of female genital tract congenital anomalies, (2013, neutral): “They represent a rather common benign condition with a prevalence of 4–7% (Grimbizis et al., 2001; Saravelos et al., 2008; Chan et al., 2011a).”
Prevalence and diagnosis of congenital uterine anomalies in women with reproductive failure: a critical appraisal. (2008, methodology): “Although the association between congenital uterine anomalies and RM has been well documented (Patton, 1994; Grimbizis et al., 2001; Homer et al., 2000; Kupesic, 2001; Taylor and Gomel, 2008), the exact prevalence in this population has not been clearly defined.”
Recurrent implantation failure: definition and management. (2014, background): “The main risk for the woman with a bicornuate uterus is mid-trimester pregnancy loss and preterm birth (Grimbizis et al., 2001).”
The prevalence of congenital uterine anomalies in unselected and high-risk populations: a systematic review (2011, background): “3% (Simon et al., 1991; Raga et al., 1997; Nahum, 1998; Homer et al., 2000; Grimbizis et al., 2001) but lower than the recent systematic review by Saravelos et al.”
Evaluation and treatment of recurrent pregnancy loss: a committee opinion. (2012, background): “6%) of patients with recurrent pregnancy loss (2 or more consecutive losses) (50).”